Colonizing the heart from the epicardial side
- PMID: 22546531
- PMCID: PMC3392775
- DOI: 10.1186/scrt106
Colonizing the heart from the epicardial side
Abstract
The clinical use of stem cells, such as bone marrow-derived and, more recently, resident cardiac stem cells, offers great promise for treatment of myocardial infarction and heart failure. The epicardium-derived cells have also attracted attention for their angiogenic paracrine actions and ability to differentiate into cardiomyocytes and vascular cells when activated during cardiac injury. In a recent study, Chong and colleagues have described a distinct population of epicardium-derived mesenchymal stem cells that reside in a perivascular niche of the heart and have a broad multilineage potential. Exploring the therapeutic capacity of these cells will be an exciting future endeavor.
Comment on
-
Adult cardiac-resident MSC-like stem cells with a proepicardial origin.Cell Stem Cell. 2011 Dec 2;9(6):527-40. doi: 10.1016/j.stem.2011.10.002. Cell Stem Cell. 2011. PMID: 22136928 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
